RxDoctor Payments Data

Tracy Posdzich

Psychiatric/Mental Health · Albany, NYNPI 1811393069

Payments from drug & device makers

$2,320in general payments, 2019–2025

Across 112 payments — averaging $20.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$625
  • Sunovion Pharmaceuticals Inc.$518
  • AbbVie$348
  • Otsuka America Pharmaceutical, Inc.$185
  • Corium, LLC$152
  • Novo Nordisk$100
  • plus $391 from 9 others

What the payments were for

  • Food & beverage$2,27398%
  • Education$472%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,320 in reported general payments places this provider in the 80th percentile of 2,385 psychiatric/mental health providers in New York.

See all psychiatric/mental health providers in New York

Medicare billing

Part B allowed, 2024
$18,814
Medicare patients
55
Services billed
187

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate14$34,834
CaplytaLumateperone Tosylate12$23,057
Lurasidone Hcl16$6,302
Aripiprazole26$1,961
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl21$1,478
Buprenorphine Hcl27$1,120
Bupropion XlBupropion Hcl48$992
Clonazepam50$658
Divalproex Sodium21$608
Duloxetine Hcl18$547
Quetiapine Fumarate49$423
Mirtazapine17$315
Trazodone Hcl51$307
Prazosin Hcl16$267
Alprazolam28$263

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$75$34,83414 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$625$23,05712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,385 psychiatric/mental health providers in New York.

Other psychiatric/mental health in Albany

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →